𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Interaction between erbB- receptors and heregulin in breast cancer tumor progression and drug resistance

✍ Scribed by Ruth Lupu; Marina Cardillo; Lyndsay Harris; Mai Hijazi; Karen Rosenberg

Book ID
112264811
Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
106 KB
Volume
6
Category
Article
ISSN
1044-579X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Bidirectional interactions between the e
Bidirectional interactions between the estrogen receptor and the c-erbB-2 signaling pathways: Heregulin inhibits estrogenic effects in breast cancer cells
✍ Thomas W. Grunt; Miguel Saceda; Mary Beth Martin; Ruth Lupu; Evelyn Dittrich; Ge πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 French βš– 993 KB

The responsiveness of estrogen receptor (ER)-positive breast cancer to endocrine therapy is frequently reduced in cells over-expressing c-erbB-2. Stimulation of ER suppresses c-erbB-2, indicating that estrogen controls the activity of c-erbB-2. Heregulin (HRG) has been described to bind to c-erbB-3/

c-erbB-2 (HER-2/neu) protein and drug re
c-erbB-2 (HER-2/neu) protein and drug resistance in breast cancer patients treated with induction chemotherapy
✍ Laura M. Vargas-Roig; Francisco E. Gago; Olga Tello; MarΓ­a T. Martin de Civetta; πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 French βš– 71 KB πŸ‘ 2 views

Expression of c-erbB-2 protein has been associated with poor prognosis and poor response to chemotherapy in breast cancer patients. In the present prospective study, we have analyzed whether c-erbB-2, p53 and P170 proteins may be determinants of tumor resistance in locally advanced breast cancer pat